Leptin is associated with increased prostate cancer risk: a nested case-referent study.
about
The impact of obesity towards prostate diseasesMetabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidencesDoes milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysisThe adipocyte-derived hormone leptin has proliferative actions on androgen-resistant prostate cancer cells linking obesity to advanced stages of prostate cancerAssociation of C-peptide and leptin with prostate cancer incidence in the Health Professionals Follow-up Study.A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survivalAdipokine genes and prostate cancer riskObesity as an important risk factor for certain types of cancerAssociation between C-peptide concentration and prostate cancer incidence in the CLUE II cohort study.Obesity, adipocytokines and cancerRacial variation in umbilical cord blood leptin concentration in male babies.Metabolic imbalance and prostate cancer progression.Promotion of melanoma growth by the metabolic hormone leptin.Global Igfbp1 deletion does not affect prostate cancer development in a c-Myc transgenic mouse modelSusceptibility of gastric cancer according to leptin and leptin receptor gene polymorphisms in Korea.Linking obesogenic dysregulation to prostate cancer progression.Serum leptin, C-reactive protein, and cancer mortality in the NHANES IIIDifferential effects of leptin on the invasive potential of androgen-dependent and -independent prostate carcinoma cells.Timing of supplementation of selenium and isoflavones determines prostate cancer risk factor reduction in rats.Dietary soy and tea combinations for prevention of breast and prostate cancers by targeting metabolic syndrome elements in mice.Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.Insulin resistance and hyperinsulinaemia in the development and progression of cancer.Superactive human leptin antagonist (SHLA), triple Lan1 and quadruple Lan2 leptin mutein as a promising treatment for human folliculomaPhase II study of sunitinib in men with advanced prostate cancer.Leptin receptor signaling via Janus kinase 2/Signal transducer and activator of transcription 3 impacts on ovarian cancer cell phenotypes.
P2860
Q26750847-99212839-F39F-4F9E-A7A6-2B6892606C12Q30234898-15970BFF-0807-40D2-9CE6-7C208CBC2C42Q30235013-7B93EB4B-1A9E-45AD-96DC-5EBA58DD9A56Q30318074-24C95426-872A-41E2-B677-1503AFD1E55BQ33640049-02B27EEF-D0FA-433C-8377-3A303221FC83Q33806363-3997E512-7671-49D8-B455-F38F62DDAE0CQ33889825-E0A2D9EC-F4E7-4A66-AF2D-318E70241612Q34082428-706B747F-A4DC-4E72-8187-CF11E0CBDA0FQ34203868-14F5DC41-70CE-4D7D-B2CF-1189A5C5790DQ34497726-26AC717E-465C-4089-B2AD-EE6A4FED99D3Q34756939-75B30D8D-26E7-4929-9F27-8FB31B813805Q34794028-7F2D081A-325F-41E6-A6E2-4518FE19CA4CQ35170649-315BF4A5-DE0E-4D19-87D4-0B5E022117E0Q35735568-A878984B-F8B1-4B19-BDE9-7723F8CA8904Q36083581-C8DDBED1-5B36-47E9-AB14-03EF080DF343Q36300793-F0AAD821-36C1-4330-BC32-683B18019E15Q36451590-26E7E487-055F-4860-8587-C70CADF6FC81Q36732591-71660396-301A-4FC2-8CE5-ACD38CD773CAQ37040298-FDABFDC7-9792-4820-9781-6222756F5CD8Q37251457-8407698D-5911-44D8-AF05-3E9DC71D1CEDQ37355770-8957FFAC-E8C1-4141-82E3-5BE085482795Q37434345-1596D328-0D17-4E42-B0F0-6AAA63FA448BQ38598392-33FB2ED5-5E94-4400-9753-93571252CC80Q39983597-5D5CFCA9-B0F6-4F53-B980-E6488AFFD377Q47108035-1E790400-AC3F-4295-8698-C68F0C7BADCD
P2860
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@ast
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@en
type
label
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@ast
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@en
prefLabel
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@ast
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@en
P2093
P50
P356
P1476
Leptin is associated with increased prostate cancer risk: a nested case-referent study.
@en
P2093
P304
P356
10.1210/JCEM.86.3.7328
P407
P577
2001-03-01T00:00:00Z